Goserelin: Side Effects, Uses & Monitoring

Facts extracted from current FDA product labeling for Goserelin. Educational only — not medical advice.

Labeled uses

ZOLADEX is a Gonadotropin Releasing Hormone (GnRH) agonist indicated for: Use in combination with flutamide for the management of locally confined carcinoma of the prostate (1.1 ) Palliative treatment of advanced carcinoma of the prostate (1.2 ) The management of endometriosis (1.3 ) Use as an endometrial-thinning agent prior to endometrial ablation for dysfunctional uterine bleeding (1.4 ) Use in the palliative treatment of advanced breast cancer in pre- and perimenopausal women (1.5 )

Source: FDA labeling via NIH DailyMed (set 294b168b…). Not affiliated with FDA or NIH.

Medical disclaimer: Always consult a qualified healthcare professional about any medication.

Ratings summarize government-reported measures — they don't capture your personal needs. Visit the facility, ask about staffing and services, and use CMS checklists. This profile is informational only and is not a recommendation.